Validation and implementation of the Australian Treatment Outcomes Profile in specialist drug and alcohol settings

Drug and Alcohol Review

Volumn 33, Issue 1, 2014, Pages 33-42

  Ryan, Anni ^a   Holmes, Jennifer ^a   Hunt, Vi ^b   Dunlop, Adrian ^b   Mammen, Kristie ^a   Holland, Rohan ^b   Sutton, Yvonne ^c   Sindhusake, Doungkamol ^d   Rivas, Gonzalo ^a   Lintzeris, Nicholas ^a  

^a SOUTH EASTERN SYDNEY LOCAL HEALTH DISTRICT   (Australia)

^b Hunter New England Drug and Alcohol Clinical Services   (Australia)

^c Sydney South West Area Drug Health Service ^*  (Australia)

^d UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

Clinical outcome monitoring; Health service evaluation; Opioid substitution treatment; Psychometric validation; Treatment outcome

Indexed keywords

ADULT; AUSTRALIA; DRUG DEPENDENCE TREATMENT; FEMALE; HUMAN; MALE; OBSERVER VARIATION; OUTCOME ASSESSMENT; PROCEDURES; PSYCHOMETRY; STANDARDS; SUBSTANCE-RELATED DISORDERS; VALIDATION STUDY; YOUNG ADULT;

ADULT; AUSTRALIA; FEMALE; HUMANS; MALE; OBSERVER VARIATION; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHOMETRICS; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84891912413     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/dar.12083     Document Type: Article

References (35)

1. Australian Institute of Health and Welfare. Alcohol and other drug treatment services in Australia 2009-10: report on the National Minimum Data Set. Drug treatment series. Canberra: Australian Institute of Health and Welfare, 2011.
2. Fromme M, Rubin G, Lyle D. The New South Wales health outcomes program. N S W Public Health Bull 1992;3:135-137.
3. Lawrinson P, Roche A, Copeland J. Optimizing clinical care through implementation of outcome monitoring systems. Drug-Educ Prev Polic 2009;16:250-259.
4. Mainz J. Defining and classifying clinical indicators for quality improvement. Int J Qual Health Care 2003;15:523-530.
5. Teesson M, Clement N, Copeland J, Conroy A, Reid A The measurement of outcome in alcohol and other drug treatment: a review of available instruments. Technical Report No. 92 National Drug and Alcohol Research Centre, 2000.
6. Overington L, Ionita G. Progress monitoring measures: a brief guide. Can Psychol 2012;53:82-92.
7. Hickie I, Andrews G, Davenport T. Measuring outcomes in patients with depression or anxiety: an essential part of clinical practice. Med J Aust 2002;177:205-207.
8. Smith G, Fischer E, Nordquist C, Mosley C, Ledbetter N. Implementing outcome management systems in mental health settings. American Psychiatric Association, ed. Outcomes assessment in mental health treatment: a compendium of articles from psychiatric services. Washington, DC: American Psychiatric Association, 1998:20-24.
9. Teruya C, Hardy M, Hser Y, Evans E. Implementation of a statewide outcome monitoring system: lessons learned from substance abuse treatment provider staff. Qual Health Res 2006;16:337-352.
10. Lawrinson P, Copeland J, Indig D. Development and validation of a brief instrument for routine outcome monitoring in opioid maintenance pharmacotherapy services: Brief Treatment Outcome Measure (BTOM). Drug Alcohol Depend 2005;80:125-133.
11. McLellan AT, Kushner H, Metzger D, etal. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat 1992;9:199-213.
12. Darke S, Hall W, Wodak A, Heather N, Ward J. Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index. Br J Addict 1992;87:733-742.
13. Marsden J, Gossop G, Stewart D, etal. The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome. Addiction 1998;93:1857-1867.
14. Tobin M, Hickie I. Outcomes focused service delivery: developing an academic-management partnership. Aust N Z J Psychiatry 1998;32:327-336.
15. Marsden J, Farrell M, Bradbury C, etal. Development of the treatment outcomes profile. Addiction 2008;103:1450-1460.
16. Marsden J, Eastwood B, Bradbury C, etal. Effectiveness of community treatments for heroin and crack cocaine addiction in England: a prospective, in-treatment cohort study. Lancet 2009;374:1262-1270.
17. Marsden J, Eastwood B, Jones H, etal. Risk adjustment of heroin treatment outcomes for comparative performance assessment in England. Addiction 2012;107:2161-2172.
18. Pulford J, Deering DE, Robinson G, etal. Development of a routine outcome monitoring instrument for use with clients in the New Zealand alcohol and other drug treatment sector: the Alcohol and Drug Outcome Measure (ADOM). NZ J Psychol 2010;39:35-45.
19. Darke S, Ward J, Hall W, Heather N, Wodak A. Opiate treatment index (OTI) manual. Sydney: National Drug and Alcohol Research Centre, University of NSW, 1991.
20. National Treatment Agency. The Treatment Outcomes Profile (TOP): a training resource to ensure the effective use of the TOP. London: National Treatment Agency, nd.
21. Kroenke K, Spitzer RL, Williams JBW. The PHQ-15: validity of a new measure for evaluating somatic symptom severity. Psychosom Med 2002;64:258-266.
22. Kessler R. Kessler's 10 psychological distress scale. Boston, MA: Harvard Medical School, 1996.
23. Andrews G, Slade T. Interpreting scores on the Kessler Psychological Distress Scale (K10). Aust N Z J Public Health 2001;25:494-497.
24. The WHOQOL Group. Development of the WHOQOL-BREF quality of life assessment. Psychol Med 1998;28:551-558.
25. Murphy B, Herrman H, Hawthorne G, Pinzone T, Evert H. Australian WHOQoL instruments: user's manual and interpretation guide. Melbourne, Vic.: Australian WHOQoL Field Study Centre, 2000.
26. Skevington S, Lofty M, O'Connell K. The World Health Organisation's WHOQoL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQoL Group. Qual Life Res 2004;13:299-310.
27. Ware J, Kosinski M, Keller SD. A 12-item Short-form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-233.
28. Sanderson K, Andrews G. The SF-12 in the Australian population: cross-validation of item selection. Aust N Z J Public Health 2002;26:343-345.
29. Fals-Stewart W, O'Farrell T, Freitas T, McFarlin S, Rutigliano P. The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties. J Consult Clin Psychol 2000;68:134-144.
30. Sobell LC, Agrawal S, Annis H, etal. Cross-cultural evaluation of two drinking assessment instruments: alcohol timeline followback and inventory of drinking situations. Subst Use Misuse 2001;36:313-331.
31. Kraemer HC, Thiemann S. How many subjects? Statistical power analysis in research. Newbury Park, CA: Sage Publications, 1987.
32. Cicchetti DV, Sparrow SA. Developing criteria for establishing interrater reliability of specific items: applications to assessment of adaptive behavior. Am J Ment Defic 1981;86:127-137.
33. Donner A, Eliasziw M. Sample size requirements for reliability studies. Stat Med 1987;6:441-448.
34. Cohen J. Statistical power analysis for the behavioral sciences. NJ: Lawrence Erlbaum Associates, 1988.
35. Easow J, Varughese S, Luty J. Criminally invalid: the treatment outcome profile form for substance misuse. Psychiatr Bull R Coll Psychiatr 2009;33:404-406.